chr15-66426931-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002755.4(MAP2K1):​c.81-8096T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.876 in 152,188 control chromosomes in the GnomAD database, including 58,653 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.88 ( 58653 hom., cov: 33)

Consequence

MAP2K1
NM_002755.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0530

Publications

19 publications found
Variant links:
Genes affected
MAP2K1 (HGNC:6840): (mitogen-activated protein kinase kinase 1) The protein encoded by this gene is a member of the dual specificity protein kinase family, which acts as a mitogen-activated protein (MAP) kinase kinase. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. This protein kinase lies upstream of MAP kinases and stimulates the enzymatic activity of MAP kinases upon wide variety of extra- and intracellular signals. As an essential component of MAP kinase signal transduction pathway, this kinase is involved in many cellular processes such as proliferation, differentiation, transcription regulation and development. [provided by RefSeq, Jul 2008]
MAP2K1 Gene-Disease associations (from GenCC):
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • cardiofaciocutaneous syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp
  • Noonan syndrome with multiple lentigines
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, ClinGen
  • Noonan syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.91 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAP2K1NM_002755.4 linkc.81-8096T>C intron_variant Intron 1 of 10 ENST00000307102.10 NP_002746.1 Q02750-1A4QPA9
MAP2K1NM_001411065.1 linkc.15-8096T>C intron_variant Intron 1 of 9 NP_001397994.1
MAP2K1XM_011521783.4 linkc.15-8096T>C intron_variant Intron 1 of 10 XP_011520085.1 B4DFY5
MAP2K1XM_017022411.3 linkc.81-8096T>C intron_variant Intron 1 of 9 XP_016877900.1 Q02750-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAP2K1ENST00000307102.10 linkc.81-8096T>C intron_variant Intron 1 of 10 1 NM_002755.4 ENSP00000302486.5 Q02750-1

Frequencies

GnomAD3 genomes
AF:
0.876
AC:
133203
AN:
152070
Hom.:
58592
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.830
Gnomad AMI
AF:
0.954
Gnomad AMR
AF:
0.859
Gnomad ASJ
AF:
0.868
Gnomad EAS
AF:
0.658
Gnomad SAS
AF:
0.888
Gnomad FIN
AF:
0.918
Gnomad MID
AF:
0.880
Gnomad NFE
AF:
0.916
Gnomad OTH
AF:
0.870
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.876
AC:
133323
AN:
152188
Hom.:
58653
Cov.:
33
AF XY:
0.876
AC XY:
65157
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.831
AC:
34469
AN:
41496
American (AMR)
AF:
0.860
AC:
13151
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.868
AC:
3013
AN:
3470
East Asian (EAS)
AF:
0.658
AC:
3400
AN:
5168
South Asian (SAS)
AF:
0.889
AC:
4285
AN:
4822
European-Finnish (FIN)
AF:
0.918
AC:
9731
AN:
10598
Middle Eastern (MID)
AF:
0.878
AC:
258
AN:
294
European-Non Finnish (NFE)
AF:
0.916
AC:
62306
AN:
68014
Other (OTH)
AF:
0.870
AC:
1840
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
840
1680
2519
3359
4199
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
896
1792
2688
3584
4480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.902
Hom.:
101852
Bravo
AF:
0.866
Asia WGS
AF:
0.790
AC:
2749
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
7.9
DANN
Benign
0.62
PhyloP100
0.053
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1432442; hg19: chr15-66719269; COSMIC: COSV107397002; API